World Journal of Diabetes - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5719)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

355

WORD

128

HTML

2792

Figures (1-1)

207

Sum=3482

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

477

Download

600

Sum=1077

Publishing Process of This Article

Item

Count

Browse

407

Download

753

Sum=1160

Oct 15, 2021 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Borovcanin MM, Vesic K, Jovanovic M, Mijailovic NR. Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireview. World J Diabetes 2021; 12(10): 1731-1739 [PMID: 34754374 DOI: 10.4239/wjd.v12.i10.1731]
URL:	https://www.wjgnet.com/1948-9358/full/v12/i10/1731.htm

Number	Citing Articles
1	Slavica Minic Janicijevic, Ivan P Jovanovic, Nevena M Gajovic, Milena M Jurisevic, Monojit Debnath, Nebojsa N Arsenijevic, Milica M Borovcanin. Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognition. World Journal of Psychiatry 2022; 12(9): 1183-1193 doi: 10.5498/wjp.v12.i9.1183 Abstract(702) \| Core Tip(426) \| Full Article(HTML)(1681) \| Full Article (PDF)-1000K(241) \| Full Article (Word)-384K(59) \| Audio-165K(2) \| Peer-Review Report-260K(88) \| Answering Reviewers-332K(66) \| Times Cited (2) \| Total Visits (6758) \| Open
2	Kah Kheng Goh, Cynthia Yi-An Chen, Tzu-Hua Wu, Chun-Hsin Chen, Mong-Liang Lu. Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction. International Journal of Molecular Sciences 2022; 23(13): 7092 doi: 10.3390/ijms23137092
3	Nataša R. Mijailović, Katarina Vesic, Dragana Arsenijevic, Maja Milojević-Rakić, Milica M. Borovcanin. Galectin-3 Involvement in Cognitive Processes for New Therapeutic Considerations. Frontiers in Cellular Neuroscience 2022; 16 doi: 10.3389/fncel.2022.923811
4	Milica M Borovcanin, Katarina Vesic, Ivica Petrovic, Ivan P Jovanovic, Nataša R Mijailović. Diabetes mellitus type 2 as an underlying, comorbid or consequent state of mental disorders. World Journal of Diabetes 2023; 14(5): 481-493 doi: 10.4239/wjd.v14.i5.481 Abstract(546) \| Core Tip(592) \| Full Article(HTML)(2693) \| Full Article (PDF)-1443K(164) \| Full Article (Word)-677K(23) \| Audio-585K(5) \| Peer-Review Report-199K(49) \| Answering Reviewers-67K(46) \| Times Cited (9) \| Total Visits (6064) \| Open
5	Milica M. Borovcanin, Bojan Stojanovic, Milica Dimitrijevic Stojanovic, Bojana S. Stojanovic, Aleksandar Lazovic, Marina Mitrovic. . Interdisciplinary Cancer Research 2024; doi: 10.1007/16833_2024_394